311 related articles for article (PubMed ID: 12548368)
1. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: long-term follow-up.
Tavella A; Bergamasco B; Bosticco E; Lanotte M; Perozzo P; Rizzone M; Torre E; Lopiano L
Neurol Sci; 2002 Sep; 23 Suppl 2():S111-2. PubMed ID: 12548368
[TBL] [Abstract][Full Text] [Related]
2. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
[TBL] [Abstract][Full Text] [Related]
4. Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations.
Østergaard K; Sunde N; Dupont E
Mov Disord; 2002 Jul; 17(4):693-700. PubMed ID: 12210858
[TBL] [Abstract][Full Text] [Related]
5. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.
Limousin P; Krack P; Pollak P; Benazzouz A; Ardouin C; Hoffmann D; Benabid AL
N Engl J Med; 1998 Oct; 339(16):1105-11. PubMed ID: 9770557
[TBL] [Abstract][Full Text] [Related]
6. [Bilateral subthalamic nucleus deep-brain stimulation (STN-DBS) in Parkinson's disease: initial experience in Cruces Hospital].
Lezcano E; Gómez JC; Lambarri I; Bilbao G; Pomposo I; Rodríguez O; Villoria R; Zarranz JJ; Madoz P; Garibi J
Neurologia; 2003 May; 18(4):187-95. PubMed ID: 12721863
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight.
Macia F; Perlemoine C; Coman I; Guehl D; Burbaud P; Cuny E; Gin H; Rigalleau V; Tison F
Mov Disord; 2004 Feb; 19(2):206-12. PubMed ID: 14978678
[TBL] [Abstract][Full Text] [Related]
8. Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients.
Thobois S; Mertens P; Guenot M; Hermier M; Mollion H; Bouvard M; Chazot G; Broussolle E; Sindou M
J Neurol; 2002 May; 249(5):529-34. PubMed ID: 12021940
[TBL] [Abstract][Full Text] [Related]
9. Chronic inhibition of the subthalamic nucleus in Parkinson's disease.
Krause M; Fogel W; Mayer P; Kloss M; Tronnier V
J Neurol Sci; 2004 Apr; 219(1-2):119-24. PubMed ID: 15050447
[TBL] [Abstract][Full Text] [Related]
10. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
Yamada K; Goto S; Hamasaki T; Kuratsu JI
Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
[TBL] [Abstract][Full Text] [Related]
11. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
[TBL] [Abstract][Full Text] [Related]
12. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
[TBL] [Abstract][Full Text] [Related]
13. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of bilateral subthalamic nucleus (STN) stimulation in Parkinson's disease.
Erola T; Heikkinen ER; Haapaniemi T; Tuominen J; Juolasmaa A; Myllylä VV
Acta Neurochir (Wien); 2006 Apr; 148(4):389-94. PubMed ID: 16284705
[TBL] [Abstract][Full Text] [Related]
15. Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?
Bejjani BP; Arnulf I; Demeret S; Damier P; Bonnet AM; Houeto JL; Agid Y
Ann Neurol; 2000 May; 47(5):655-8. PubMed ID: 10805339
[TBL] [Abstract][Full Text] [Related]
16. [Variance in effects of subthalamic nucleus stimulation].
Okiyama R; Yokochi F; Taniguchi M; Takahashi H; Hasegawa N; Hamada I
No To Shinkei; 2002 Oct; 54(10):883-8. PubMed ID: 12476577
[TBL] [Abstract][Full Text] [Related]
17. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
[TBL] [Abstract][Full Text] [Related]
18. Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus.
Østergaard K; Aa Sunde N
Mov Disord; 2006 May; 21(5):624-31. PubMed ID: 16283616
[TBL] [Abstract][Full Text] [Related]
19. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
[TBL] [Abstract][Full Text] [Related]
20. Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa.
Lyons KE; Davis JT; Pahwa R
Stereotact Funct Neurosurg; 2007; 85(4):169-74. PubMed ID: 17259749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
